Report Detail
Global Sevoflurane and Desflurane Anaesthetics Market Growth 2022-2028
- RnM4486091 |
- 24 August, 2022 |
- Global |
- 94 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
The global market for Sevoflurane and Desflurane Anaesthetics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Sevoflurane and Desflurane Anaesthetics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Sevoflurane and Desflurane Anaesthetics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Sevoflurane and Desflurane Anaesthetics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Sevoflurane and Desflurane Anaesthetics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Sevoflurane and Desflurane Anaesthetics players cover Piramal Critical Care (PCC), Halocarbon Life Sciences, Baxter, Hengrui Medicine and AbbVie, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Sevoflurane and Desflurane Anaesthetics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Sevoflurane and Desflurane Anaesthetics market, with both quantitative and qualitative data, to help readers understand how the Sevoflurane and Desflurane Anaesthetics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in L.
Market Segmentation:
The study segments the Sevoflurane and Desflurane Anaesthetics market and forecasts the market size by Type (Sevoflurane and Desflurane,), by Application (Hospital and Clinic.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Sevoflurane
Desflurane
Segmentation by application
Hospital
Clinic
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Piramal Critical Care (PCC)
Halocarbon Life Sciences
Baxter
Hengrui Medicine
AbbVie
Lunan Pharmaceutical Group
Maruishi Pharmaceutical Co.,Ltd.
Ilsung Pharmaceuticals
Chapter Introduction
Chapter 1: Scope of Sevoflurane and Desflurane Anaesthetics, Research Methodology, etc.
Chapter 2: Executive Summary, global Sevoflurane and Desflurane Anaesthetics market size (sales and revenue) and CAGR, Sevoflurane and Desflurane Anaesthetics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Sevoflurane and Desflurane Anaesthetics sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Sevoflurane and Desflurane Anaesthetics sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Sevoflurane and Desflurane Anaesthetics market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Piramal Critical Care (PCC), Halocarbon Life Sciences, Baxter, Hengrui Medicine, AbbVie, Lunan Pharmaceutical Group, Maruishi Pharmaceutical Co.,Ltd. and Ilsung Pharmaceuticals, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Sevoflurane and Desflurane Anaesthetics Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Sevoflurane and Desflurane Anaesthetics by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Sevoflurane and Desflurane Anaesthetics by Country/Region, 2017, 2022 & 2028
- 2.2 Sevoflurane and Desflurane Anaesthetics Segment by Type
- 2.2.1 Sevoflurane
- 2.2.2 Desflurane
- 2.3 Sevoflurane and Desflurane Anaesthetics Sales by Type
- 2.3.1 Global Sevoflurane and Desflurane Anaesthetics Sales Market Share by Type (2017-2022)
- 2.3.2 Global Sevoflurane and Desflurane Anaesthetics Revenue and Market Share by Type (2017-2022)
- 2.3.3 Global Sevoflurane and Desflurane Anaesthetics Sale Price by Type (2017-2022)
- 2.4 Sevoflurane and Desflurane Anaesthetics Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.5 Sevoflurane and Desflurane Anaesthetics Sales by Application
- 2.5.1 Global Sevoflurane and Desflurane Anaesthetics Sale Market Share by Application (2017-2022)
- 2.5.2 Global Sevoflurane and Desflurane Anaesthetics Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Sevoflurane and Desflurane Anaesthetics Sale Price by Application (2017-2022)
3 Global Sevoflurane and Desflurane Anaesthetics by Company
- 3.1 Global Sevoflurane and Desflurane Anaesthetics Breakdown Data by Company
- 3.1.1 Global Sevoflurane and Desflurane Anaesthetics Annual Sales by Company (2020-2022)
- 3.1.2 Global Sevoflurane and Desflurane Anaesthetics Sales Market Share by Company (2020-2022)
- 3.2 Global Sevoflurane and Desflurane Anaesthetics Annual Revenue by Company (2020-2022)
- 3.2.1 Global Sevoflurane and Desflurane Anaesthetics Revenue by Company (2020-2022)
- 3.2.2 Global Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Company (2020-2022)
- 3.3 Global Sevoflurane and Desflurane Anaesthetics Sale Price by Company
- 3.4 Key Manufacturers Sevoflurane and Desflurane Anaesthetics Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Sevoflurane and Desflurane Anaesthetics Product Location Distribution
- 3.4.2 Players Sevoflurane and Desflurane Anaesthetics Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sevoflurane and Desflurane Anaesthetics by Geographic Region
- 4.1 World Historic Sevoflurane and Desflurane Anaesthetics Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Sevoflurane and Desflurane Anaesthetics Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Sevoflurane and Desflurane Anaesthetics Annual Revenue by Geographic Region
- 4.2 World Historic Sevoflurane and Desflurane Anaesthetics Market Size by Country/Region (2017-2022)
- 4.2.1 Global Sevoflurane and Desflurane Anaesthetics Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Sevoflurane and Desflurane Anaesthetics Annual Revenue by Country/Region
- 4.3 Americas Sevoflurane and Desflurane Anaesthetics Sales Growth
- 4.4 APAC Sevoflurane and Desflurane Anaesthetics Sales Growth
- 4.5 Europe Sevoflurane and Desflurane Anaesthetics Sales Growth
- 4.6 Middle East & Africa Sevoflurane and Desflurane Anaesthetics Sales Growth
5 Americas
- 5.1 Americas Sevoflurane and Desflurane Anaesthetics Sales by Country
- 5.1.1 Americas Sevoflurane and Desflurane Anaesthetics Sales by Country (2017-2022)
- 5.1.2 Americas Sevoflurane and Desflurane Anaesthetics Revenue by Country (2017-2022)
- 5.2 Americas Sevoflurane and Desflurane Anaesthetics Sales by Type
- 5.3 Americas Sevoflurane and Desflurane Anaesthetics Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Sevoflurane and Desflurane Anaesthetics Sales by Region
- 6.1.1 APAC Sevoflurane and Desflurane Anaesthetics Sales by Region (2017-2022)
- 6.1.2 APAC Sevoflurane and Desflurane Anaesthetics Revenue by Region (2017-2022)
- 6.2 APAC Sevoflurane and Desflurane Anaesthetics Sales by Type
- 6.3 APAC Sevoflurane and Desflurane Anaesthetics Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Sevoflurane and Desflurane Anaesthetics by Country
- 7.1.1 Europe Sevoflurane and Desflurane Anaesthetics Sales by Country (2017-2022)
- 7.1.2 Europe Sevoflurane and Desflurane Anaesthetics Revenue by Country (2017-2022)
- 7.2 Europe Sevoflurane and Desflurane Anaesthetics Sales by Type
- 7.3 Europe Sevoflurane and Desflurane Anaesthetics Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Sevoflurane and Desflurane Anaesthetics by Country
- 8.1.1 Middle East & Africa Sevoflurane and Desflurane Anaesthetics Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Sevoflurane and Desflurane Anaesthetics Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Sevoflurane and Desflurane Anaesthetics Sales by Type
- 8.3 Middle East & Africa Sevoflurane and Desflurane Anaesthetics Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Sevoflurane and Desflurane Anaesthetics
- 10.3 Manufacturing Process Analysis of Sevoflurane and Desflurane Anaesthetics
- 10.4 Industry Chain Structure of Sevoflurane and Desflurane Anaesthetics
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Sevoflurane and Desflurane Anaesthetics Distributors
- 11.3 Sevoflurane and Desflurane Anaesthetics Customer
12 World Forecast Review for Sevoflurane and Desflurane Anaesthetics by Geographic Region
- 12.1 Global Sevoflurane and Desflurane Anaesthetics Market Size Forecast by Region
- 12.1.1 Global Sevoflurane and Desflurane Anaesthetics Forecast by Region (2023-2028)
- 12.1.2 Global Sevoflurane and Desflurane Anaesthetics Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Sevoflurane and Desflurane Anaesthetics Forecast by Type
- 12.7 Global Sevoflurane and Desflurane Anaesthetics Forecast by Application
13 Key Players Analysis
- 13.1 Piramal Critical Care (PCC)
- 13.1.1 Piramal Critical Care (PCC) Company Information
- 13.1.2 Piramal Critical Care (PCC) Sevoflurane and Desflurane Anaesthetics Product Offered
- 13.1.3 Piramal Critical Care (PCC) Sevoflurane and Desflurane Anaesthetics Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 Piramal Critical Care (PCC) Main Business Overview
- 13.1.5 Piramal Critical Care (PCC) Latest Developments
- 13.2 Halocarbon Life Sciences
- 13.2.1 Halocarbon Life Sciences Company Information
- 13.2.2 Halocarbon Life Sciences Sevoflurane and Desflurane Anaesthetics Product Offered
- 13.2.3 Halocarbon Life Sciences Sevoflurane and Desflurane Anaesthetics Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Halocarbon Life Sciences Main Business Overview
- 13.2.5 Halocarbon Life Sciences Latest Developments
- 13.3 Baxter
- 13.3.1 Baxter Company Information
- 13.3.2 Baxter Sevoflurane and Desflurane Anaesthetics Product Offered
- 13.3.3 Baxter Sevoflurane and Desflurane Anaesthetics Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 Baxter Main Business Overview
- 13.3.5 Baxter Latest Developments
- 13.4 Hengrui Medicine
- 13.4.1 Hengrui Medicine Company Information
- 13.4.2 Hengrui Medicine Sevoflurane and Desflurane Anaesthetics Product Offered
- 13.4.3 Hengrui Medicine Sevoflurane and Desflurane Anaesthetics Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 Hengrui Medicine Main Business Overview
- 13.4.5 Hengrui Medicine Latest Developments
- 13.5 AbbVie
- 13.5.1 AbbVie Company Information
- 13.5.2 AbbVie Sevoflurane and Desflurane Anaesthetics Product Offered
- 13.5.3 AbbVie Sevoflurane and Desflurane Anaesthetics Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 AbbVie Main Business Overview
- 13.5.5 AbbVie Latest Developments
- 13.6 Lunan Pharmaceutical Group
- 13.6.1 Lunan Pharmaceutical Group Company Information
- 13.6.2 Lunan Pharmaceutical Group Sevoflurane and Desflurane Anaesthetics Product Offered
- 13.6.3 Lunan Pharmaceutical Group Sevoflurane and Desflurane Anaesthetics Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 Lunan Pharmaceutical Group Main Business Overview
- 13.6.5 Lunan Pharmaceutical Group Latest Developments
- 13.7 Maruishi Pharmaceutical Co.,Ltd.
- 13.7.1 Maruishi Pharmaceutical Co.,Ltd. Company Information
- 13.7.2 Maruishi Pharmaceutical Co.,Ltd. Sevoflurane and Desflurane Anaesthetics Product Offered
- 13.7.3 Maruishi Pharmaceutical Co.,Ltd. Sevoflurane and Desflurane Anaesthetics Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 Maruishi Pharmaceutical Co.,Ltd. Main Business Overview
- 13.7.5 Maruishi Pharmaceutical Co.,Ltd. Latest Developments
- 13.8 Ilsung Pharmaceuticals
- 13.8.1 Ilsung Pharmaceuticals Company Information
- 13.8.2 Ilsung Pharmaceuticals Sevoflurane and Desflurane Anaesthetics Product Offered
- 13.8.3 Ilsung Pharmaceuticals Sevoflurane and Desflurane Anaesthetics Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.8.4 Ilsung Pharmaceuticals Main Business Overview
- 13.8.5 Ilsung Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Sevoflurane and Desflurane Anaesthetics. Industry analysis & Market Report on Sevoflurane and Desflurane Anaesthetics is a syndicated market report, published as Global Sevoflurane and Desflurane Anaesthetics Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Sevoflurane and Desflurane Anaesthetics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
